EquityZen Growth Technology Fund LLC - Series 527
Raised
$641K
Investors
26
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 527 is a Delaware-based pooled investment fund that raised $641K from 26 investors under Rule 506(b) and 3(c)(1) exemptions, with a $10K minimum investment. Filed February 18, 2020 by EquityZen Advisors LLC, this vehicle is part of the EquityZen platform, which operates 1,891 related entities providing secondary market access to pre-IPO company shares.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption combination typical of private secondary market vehicles, with a $10K minimum investment positioned at the accessible end of the pre-IPO spectrum. The ~$25K average investor commitment and series-specific structure are consistent with EquityZen's model of creating individual SPVs for discrete pre-IPO company positions.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
